Atezolizumab plus Stereotactic Ablative Radiotherapy for Medically Inoperable Patients with Early-Stage Non-Small Cell Lung Cancer: A Multi-Institutional Phase I trial.
Twenty patients enrolled in a multi-institutional phase I study evaluating safety, maximum tolerated dose (MTD), efficacy, and mechanistic correlatives. Sequencing of PBMCs from 8 patients at baseline to cycle 4.